BamSEC and AlphaSense Join Forces
Learn More

Cocrystal Pharma Inc.

NASDAQ: COCP    
Share price (1/6/25): $2.40    
Market cap (1/6/25): $24.4 million

Articles of Incorporation Filter

EX-3.1
from 10-Q 3 pages Certificate of Incorporation of Cocrystal Pharma, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Certificate of Incorporation of Cocrystal Pharma, Inc
12/34/56
EX-3.1
from 8-K 1 page Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 10-Q 4 pages Certificate of Incorporation of Cocrystal Pharma, Inc
12/34/56
EX-3.1
from 8-K 15 pages Amended and Restated Bylaws of Cocrystal Pharma, Inc
12/34/56
EX-3.1
from 10-Q 5 pages Certificate of Incorporation of Cocrystal Pharma, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to Certificate of Incorporation
12/34/56
EX-3.1
from 10-K 16 pages Certificate of Incorporation of Cocrystal Holdings, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to Certificate of Incorporation of Cocrystal Pharma, Inc
12/34/56
EX-3.6
from 8-K 10 pages Amended and Restated Bylaws of Cocrystal Pharma, Inc
12/34/56
EX-3.5
from 8-K 1 page Amendment to Certificate of Incorporation of Cocrystal Pharma, Inc
12/34/56
EX-3.4
from 8-K 10 pages Bylaws of Cocrystal Holdings, Inc
12/34/56
EX-3.3
from 8-K 3 pages Amendment to Certificate of Incorporation of Cocrystal Holdings, Inc. David Block Phillip Frost Jeffrey Meckler Steven Rubin Raymond Schinazi Gary Wilcox Jane Hsiao
12/34/56
EX-3.2
from 8-K 5 pages Certificate of Incorporation of Cocrystal Holdings, Inc
12/34/56
EX-3.1
from 8-K 11 pages Cocrystal Holdings, Inc Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock
12/34/56
EX-3.9
from 10-K/A 9 pages Bylaws of Cocrystal Pharma, Inc
12/34/56
EX-3.7
from 10-K/A 4 pages Certificate of Incorporation of Cocrystal Pharma, Inc
12/34/56
EX-3.9
from 10-K 9 pages Bylaws of Cocrystal Pharma, Inc
12/34/56
EX-3.7
from 10-K 4 pages Certificate of Incorporation of Cocrystal Pharma, Inc
12/34/56
EX-3.1
from 8-K 4 pages Biozone Pharmaceuticals, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock
12/34/56